All || Biopharma || Diagnostics and Life Science Tools || Medical Device || Healthcare IT || Healthcare Services || Exited


Fully integrated, profitable biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China

IPO in May 2015 (HKSE: 1530)

AADI Bioscience

Clinical stage biopharmaceutical company developing a nanoparticle albumin-bound mTOR inhibitor based on sirolimus or rapamycin, also known as nab-rapamycin


Molecular diagnostics based in Shanghai and Silicon Valley providing cell-free DNA based liquid biopsy tests for personalized cancer treatment and monitoring

Adaptive Biotechnologies

Diagnostics company developing immune-driven medicine that aims to improve people’s lives by learning from the wisdom of their adaptive immune systems

IPO in June 2019 (NASDAQ: ADPT)

AK Medical

Largest domestic manufacturer of hip and knee artificial joints in China

IPO in December 2017 (HKSE: 1789)

Albireo Pharma

Clinical stage biopharma company focused on the development of novel bile acid modulators to treat orphan pediatric liver diseases, and other adult liver diseases and disorders


Alpine Immune Sciences

Biotech company developing innovative treatments for patients suffering from cancer and autoimmune/inflammatory diseases


AnHeart Therapeutics

Clinical stage biopharmaceutical company based in China focused on the acquisition, development and commercialization of oncology products


Clinical-stage biopharmaceutical company focusing on the discovery and development of innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology

Arcus Biosciences

Clinical-stage biotechnology company focused on the discovery and development of innovative cancer immunotherapies

IPO in March 2018 (NASDAQ:RCUS)


Biotech company founded by Decheng Capital to develop a novel class of small molecules as cancer immunotherapies

Ark Biosciences

Ark Biosciences is a biotech startup company focusing on innovative drug discovery and development, especially in the respiratory virus field, for world-wide markets

ARMO Biosciences

Late-stage immuno-oncology company that is developing a pipeline of novel, proprietary products that activate the immune system of cancer patients to recognize and eradicate tumors

Acquired by Eli Lilly in May 2018


Global leading food/vegetable ingredient supplier with a full supply chain control and strategically aligned global distribution platform


Clinical-stage biopharmaceutical company developing plinabulin, an anti-cancer agent



Biotech company based in China developing universal CAR-T products


Medical device company addressing the large and growing market for advanced cardiovascular devices in China

Cellular Research

Life science tools company developing a next-generation single cell preparation technology

Acquired by Becton Dickinson in August 2015

Centricity Vision

Medical device company focused on development and commercialization of its Zepto? device for cataract surgery

Checkmate Pharmaceuticals

Clinical stage biopharma company that is leveraging its expertise in the field of CpG oligonucleotides to discover and develop immunotherapies designed to increase the efficacy of existing immunotherapies

IPO in August 2020 (NASDAQ: CMPI)


Diagnostics compaby based in Hong Kong and Silicon Valley developing proprietary plasma-based early cancer screening/detection utilizing next-generation sequencing

Acquired by GRAIL in May 2017

Cue Health

Molecular diagnostics company developing products that can be used in clinical or at-home settings


Life science tools company that plans to develop and commercialize next-generation proteomic assays which can be decentralized

EpimAb Biotherapeutics

Biopharmaceutical company dedicated to generating novel bi-specific antibody therapeutics based on its proprietary FIT-Ig (Fabs-In-Tandem) platform

Everest Medicines

Biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients in Greater China and other parts of Asia

IPO in October 2020 (HKSE: 1952)


Life science tools company developing a disruptive DNA-sequencing technology that enables fast, accurate, and ultra-low cost genetic testing and research


Diagnostic company with commercialization in China and innovative technologies developed in Silicon Valley


Diagnostics company developing and commercializing products for bacterial susceptibility testing for surveillance of hospital acquired infections

Acquired by Roche in August 2015


Healthcare company whose mission is to detect cancer early, when it can be cured

Acquired by Illumina in September 2020

Guanlong Medical

The market leader in minimally invasive spine surgery devices in China

GRIT Biotechnology

Biotech company developing tumor infiltration lymphocytes immunotherapy for solid tumors


GYT Healthcare Services

Leading domestic hemodialysis service provider in China


Hummingbird Bioscience

Biotech company, with facilities in Singapore and Silicon Valley, focused on applying advances in systems biology to rapidly develop antibodies into successful cancer therapeutics


IMPACT Therapeutics

Clinical stage biopharmaceutical company based in China focusing on discovery and development of best-in-class anti-cancer drugs targeting a poly (ADP-ribose) polymerase (PARP)

Insight Lifetech

Medical device company dedicated to developing world class interventional diagnostic cardiology devices


Genetic information company with a mission to bring comprehensive genetic information into mainstream medical practice to improve the quality of healthcare for billions of people

IPO in February 2016 (NASDAQ: NVTA)

KeChow Pharma

Clinical-stage biotech based in China focused on developing small molecules for clinically validated oncology targets

Ketai Medical

Medical device company focusing on registration and commercialization of innovative and FDA-approved prosthetic hip and knee joint implants for the China market

Kind Pharmaceutical

Clinical stage biopharmaceutical company based in China focusing on discovery and development of best-in-class anemia drugs


Early stage life science tools company developing a single-cell imaging and profiling platform based on magnetic levitation technology invented at Stanford and Harvard universities

LYNK Pharmaceuticals

Preclinical stage biotech comapny focused on researching and developing JAK family small molecules

Mammoth Biosciences

Healthcare company who is harnessing the diversity of nature to power the next-generation of CRISPR products


The market leader in ophthalmology medical device in China

Mindstrong Health

Digital health startup developing and offering an artificial intelligence powered platform designed through an app to monitor patterns of interaction on smartphone devices to objective measures of brain function

Nalu Medical

Medical device company focused on development and commercialization of novel neurostimulation system


Life science tools company focused on development and commercialization of next generation DNA sequencing platform

PackGene Biotech

PackGene is a CRO/CDMO service provider for global gene therapy and cell therapy researchers and developers

Polares Medical

Medical device company developing a novel implant and delivery system for the treatment of mitral valve regurgitation


Life science tools company developing RNA sequencing technology by delivering the first panomic spatial sequencing platform

Acquired by 10X Genomics in October 2020


Biotech company developing innovative therapies for difficult-to-treat and often life-threatening infections



Patient-centered health intelligence company founded on the idea that more information, deeper analysis, and increased engagement will improve the diagnosis, treatment, and prevention of disease


Medical device company with a novel suture delivery and tissue closure device for for patients with atrial fibrillation

Acquired by Atricure in August 2018

SINO Medical Sciences Technology

Medical device company dedicated to developing, manufacturing and commercializing products for percutaneous coronary intervention for the Chinese market

IPO in October 2019 (SHA: 688108)


Healthcare technology company aiming to disrupt healthcare inventions widely accessible to the public in China and Asia

Terns Pharmaceuticals

Clinical stage biopharma company based in Shanghai and Silicon Valley developing oral, small molecule drugs for nonalcoholic steatohepatitis (NASH), a liver disease


Biopharma company focused on developing an antibody-drug conjugate of cirmtuzumab, a ROR1 antibody

Acquired by Merck in November 2020

Copyright ? 2011 Decheng Capital LLC. All Rights Reserved.
浙江20选5预测推荐 广东麻将心法口诀 东方六加一走势图 彩票吉林11选5查询 百宝彩票山西快乐十分 分分彩走势图如何看 tcl股票投资分析 半全场单关什么意思 云南11选5投注技巧 阳光币app下载 美女棋牌a决战一晚图片 好友联机麻将手游 购买体彩的app 山东麻将游戏下载 吉林时时彩开奖结果查询 福建22选5中奖规则 新疆喜乐彩五分彩